Maxim Group Starts Proteon Therapeutics (PRTO) at Buy
News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here.
Maxim Group initiated coverage on Proteon Therapeutics (NASDAQ: PRTO) with a Buy rating and a price target of $19.00.
Shares of Proteon Therapeutics closed at $9.25 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- UPDATE: Seaport Global Securities Starts Owens Corning (OC) at Buy
- Raymond James Starts YPF S.A. (YPF) at Outperform
- Deutsche Bank Downgrades MGM Growth Properties (MGP) to Hold